Breast Imaging Market Trends, Strategies, Potential Growth and Demand Analysis Forecast to 2027

Breast Imaging Market Overview

The global breast imaging market size can expand at a CAGR of 8.38% from 2021 to 2027 (forecast period) due to rising cases of breast cancer. According to the World Health Organization (WHO), breast cancer is the second biggest form of cancer with more than 200,000 cases being discerned globally.  Technological breakthroughs in diagnostic equipment and increase in healthcare expenditure of developed and developing economies for tackling the disease can work in favor of the market.

Government initiatives for creating awareness among both the genders as well as new imaging methods for conducting faster breast biopsies can drive the market growth. For instance, the SAVI SCOUT technology can be used to pinpoint the exact location of the tumor by surgeons with the help of an infrared reflector. The need for minimally invasive procedures for biopsies can widen the growth prospects of the global breast imaging market.

But the high cost of breast imaging solutions and low awareness levels of breast cancer among women in low-income economies can restrain the market growth.

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5612

Competitive Analysis:

Leading players in the global breast imaging market include Sonocine Inc., Toshiba Corporation, Gamma Medica Inc., Aurora Imaging Technology Inc., Dilon Technologies Inc., Fujifilm Holdings Corporation, Hologic Inc., Koninklijke Philips N.V., Siemens, and GE. 

In September 2019, Candelis Inc. launched a new Advanced Breast Imaging Workstation as an enhancement to its ImageGrid platform. 

Segmentation

The global breast imaging market is segmented into technology, end user, and region. The technology segment is further segmented into ionizing technology, non-ionizing technology, and others. Ionizing technology is further sub-segmented into mammography, Molecular Breast Imaging (MBI)/molecular Breast-Specific Gamma Imaging (BSGI),PET-CT, Contrast-Enhanced Spectral Mammography (CESM),and cone-beam computed mammography. Mammography is further sub-segmentedinto digital mammography/Full-Field Digital Mammography (FFDM),3D mammogram/3D breast tomosynthesis, Positron Emission Mammography (PEM),and analog mammography. The non-ionizing technology segment is further sub-segmented into breast ultrasound,breast MRI,breast thermography,optical imaging,microwave imaging, Electrical Impedance Imaging (EII), and others. The end user segment is further segmented into hospitals & clinics, specialty centers, and others.

Regional Analysis:

The Americas is the largest regional market for breast imaging. The widespread awareness about breast cancer in the region has been a primary driver for the breast imaging market, as it has driven consistent product development in the breast imaging market. Women in the country don’t view breast cancer as a taboo and are proactive in fighting the disease on their own terms. This has driven significant growth of the breast imaging market. The growing prevalence of breast cancer in the region is also likely to remain a major driver for the breast imaging market in the Americas. 

Europe holds the second largest share in the global breast imaging market, followed by Asia Pacific. China, Japan, and India are likely to emerge as important markets in the coming years, enabling steady growth of the breast imaging market in Asia Pacific.

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 16

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 19

TABLE 3 GLOBAL BREAST IMAGING MARKET, BY TECHNOLOGY, 2018-2027 (USD MILLION) 35

TABLE 4 GLOBAL BREAST IMAGING MARKET, FOR IONIZING TECHNOLOGY, BY REGION, 2018-2027 (USD MILLION) 36

TABLE 5 GLOBAL BREAST IMAGING MARKET, FOR IONIZING TECHNOLOGY, BY TYPE, 2018-2027 (USD MILLION) 37

TABLE 6 GLOBAL BREAST IMAGING MARKET, FOR MAMMOGRAPHY, BY REGION, 2018-2027 (USD MILLION) 37